The world's first mRNA-interleukin-2 preparation has completed Phase I clinical trial
Datetime：2026-09-11
View volume：
Led by Professor Wang Kai, the world's first mRNA-interleukin-2 preparation has completed Phase I clinical trial. It passed the review by the US FDA in November 2025 and advanced into Phase II clinical stage, with an international multi-center collaborative study launched in partnership with Massachusetts General Hospital.
Previous：No record.
Next：No record.